Auxly Cannabis Group Inc
OTC:CBWTF

Watchlist Manager
Auxly Cannabis Group Inc Logo
Auxly Cannabis Group Inc
OTC:CBWTF
Watchlist
Price: 0.08 USD 5.26% Market Closed
Market Cap: 100.2m USD

Relative Value

CBWTF doesn't have a meaningful market cap.

The Relative Value of one CBWTF stock under the Base Case scenario is 0.06 USD. Compared to the current market price of 0.08 USD, Auxly Cannabis Group Inc is Overvalued by 19%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

CBWTF Relative Value
Base Case
0.06 USD
Overvaluation 19%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
39
vs Industry
70
Median 3Y
0.4
Median 5Y
0.7
Industry
2.5
Forward
0.9
vs History
0
vs Industry
Median 3Y
-0.5
Median 5Y
-1.1
Industry
21.2
vs History
9
vs Industry
47
Median 3Y
2.5
Median 5Y
-1.9
Industry
16.3
vs History
0
vs Industry
26
Median 3Y
-1
Median 5Y
-1.9
Industry
23.8
vs History
9
vs Industry
61
Median 3Y
0.4
Median 5Y
0.6
Industry
2.1
vs History
71
vs Industry
65
Median 3Y
1.1
Median 5Y
1.6
Industry
2.6
Forward
0.9
vs History
61
vs Industry
29
Median 3Y
4
Median 5Y
15.9
Industry
5.2
vs History
vs Industry
Median 3Y
-3.7
Median 5Y
-5.6
Industry
12.5
Forward
7.9
vs History
vs Industry
Median 3Y
-2.6
Median 5Y
-3.4
Industry
15.9
Forward
-21.7
vs History
28
vs Industry
45
Median 3Y
5.6
Median 5Y
-4.1
Industry
14.6
vs History
19
vs Industry
34
Median 3Y
4.2
Median 5Y
-5
Industry
17.2
vs History
38
vs Industry
66
Median 3Y
0.5
Median 5Y
0.5
Industry
1.8

Multiples Across Competitors

CBWTF Competitors Multiples
Auxly Cannabis Group Inc Competitors

Market Cap P/S P/E EV/EBITDA EV/EBIT
CA
Auxly Cannabis Group Inc
OTC:CBWTF
151.2m USD 1.2 6.9 -17.2 -7.8
US
Eli Lilly and Co
NYSE:LLY
738.5B USD 15.1 66.5 35.7 39
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
374.2B USD 4.2 17.2 12.5 16.5
DK
Novo Nordisk A/S
CSE:NOVO B
2T DKK 6.5 18.8 13 15
CH
Roche Holding AG
SIX:ROG
206.7B CHF 3.4 25 9.4 11
CH
Novartis AG
SIX:NOVN
191.4B CHF 4.5 18.8 11 14.8
UK
AstraZeneca PLC
LSE:AZN
161.9B GBP 4 28.4 130.9 197.3
US
Merck & Co Inc
NYSE:MRK
207.3B USD 3.2 11.9 8.8 10.7
IE
Endo International PLC
LSE:0Y5F
163.5B USD 70.5 -56 261.3 655.3
US
Pfizer Inc
NYSE:PFE
143.9B USD 2.3 18.3 7.8 10.9
P/E Multiple
Earnings Growth PEG
CA
Auxly Cannabis Group Inc
OTC:CBWTF
Average P/E: 23.5
6.9
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
66.5
49%
1.4
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
17.2
27%
0.6
DK
Novo Nordisk A/S
CSE:NOVO B
18.8
18%
1
CH
Roche Holding AG
SIX:ROG
25
32%
0.8
CH
Novartis AG
SIX:NOVN
18.8
17%
1.1
UK
AstraZeneca PLC
LSE:AZN
28.4
36%
0.8
US
Merck & Co Inc
NYSE:MRK
11.9
17%
0.7
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -56 N/A N/A
US
Pfizer Inc
NYSE:PFE
18.3
30%
0.6
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CA
Auxly Cannabis Group Inc
OTC:CBWTF
Average EV/EBITDA: 433.7
Negative Multiple: -17.2
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
35.7
30%
1.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
12.5
7%
1.8
DK
Novo Nordisk A/S
CSE:NOVO B
13
13%
1
CH
Roche Holding AG
SIX:ROG
9.4
5%
1.9
CH
Novartis AG
SIX:NOVN
11
5%
2.2
UK
AstraZeneca PLC
LSE:AZN
130.9
10%
13.1
US
Merck & Co Inc
NYSE:MRK
8.8
8%
1.1
IE
E
Endo International PLC
LSE:0Y5F
261.3
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.8
2%
3.9
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
CA
Auxly Cannabis Group Inc
OTC:CBWTF
Average EV/EBIT: 1 867.3
Negative Multiple: -7.8
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
39
32%
1.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
16.5
13%
1.3
DK
Novo Nordisk A/S
CSE:NOVO B
15
14%
1.1
CH
Roche Holding AG
SIX:ROG
11
6%
1.8
CH
Novartis AG
SIX:NOVN
14.8
10%
1.5
UK
AstraZeneca PLC
LSE:AZN
197.3
23%
8.6
US
Merck & Co Inc
NYSE:MRK
10.7
11%
1
IE
E
Endo International PLC
LSE:0Y5F
655.3
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.9
10%
1.1